20/04/2015 - 19:43 Of all drugs to be released in 2015, the melanoma drug Opdivo (nivolumab) is expected to have the brightest future, according to a report from Thomson... More » Visit websiteField of Interest: OncologyCategories: CME-candidateFPN || Practice EconomicsIMN || Practice EconomicsOBGYN || Practice EconomicsCHEST || Practice EconomicsCEN || Practice EconomicsCPN || Practice EconomicsCEN || GraphicCEN || NewsCEN || DiabetesNews Feed: Internal Medicine News - Oncology